Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

SHE:002728 Revenue

Teyi Pharmaceutical Group Co.,Ltd had revenue of 230.22M CNY in the quarter ending September 30, 2026, with 14.71% growth. This brings the company's total for the last twelve months to 856.22M, down -7.34% year-over-year. In the year 2025, Teyi Pharmaceutical Group Co.,Ltd had annual revenue of 924.53M with 34.42% growth. That makes Teyi Pharmaceutical Group Co.,Ltd the 20,835th largest company in the world by revenue and 3,828th in China.

• Revenue (ttm): 856.22M
• Revenue Growth: -7.34%
• P/S Ratio: 5.46
• Revenue / Employee: 597.09K
• Employees: 1,434
• Market Cap: 4.66B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry 908.06M 98.2%
• Pharmaceutical Business 9.46M 1.0%
• Chemical Products and Others 7.01M 0.8%

By Geography

Chart

• South China 486.68M 52.6%
• East China 157.95M 17.1%
• Northeast 75.93M 8.2%
• Southwest 62.04M 6.7%
• North China 52.97M 5.7%
• Central China 52.12M 5.6%
• Northwest 35.96M 3.9%
• Overseas 869.17K 0.1%

Fiscal year ended Dec 31, 2025 See the full SHE:002728 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	924.53M	236.74M	34.42%
Dec 31, 2024	687.79M	-379.43M	-35.55%
Dec 31, 2023	1.07B	180.64M	20.38%
Dec 31, 2022	886.57M	128.41M	16.94%
Jan 1, 2022	758.16M	125.47M	19.83%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error